Manu Shankar-Hari, Thierry Calandra, Miguel P Soares, Michael Bauer, W Joost Wiersinga, Hallie C Prescott, Julian C Knight, Kenneth J Baillie, Lieuwe D J Bos, Lennie P G Derde, Simon Finfer, Richard S Hotchkiss, John Marshall, Peter J M Openshaw, Christopher W Seymour, Fabienne Venet, Jean-Louis Vincent, Christophe Le Tourneau, Anke H Maitland-van der Zee, Iain B McInnes, Tom van der Poll
Sepsis is a common and deadly condition. Within the current model of sepsis immunobiology, the framing of dysregulated host immune responses into proinflammatory and immunosuppressive responses for the testing of novel treatments has not resulted in successful immunomodulatory therapies. Thus, the recent focus has been to parse observable heterogeneity into subtypes of sepsis to enable personalised immunomodulation. In this Personal View, we highlight that many fundamental immunological concepts such as resistance, disease tolerance, resilience, resolution, and repair are not incorporated into the current sepsis immunobiology model...
February 23, 2024: Lancet Respiratory Medicine